EP Patent

EP3862007A1 — Sodium nitrite-containing pharmaceutical compositions

Assigned to Hope Medical Enterprises Inc · Expires 2021-08-11 · 5y expired

What this patent protects

Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing …

USPTO Abstract

Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.

Drugs covered by this patent

Patent Metadata

Patent number
EP3862007A1
Jurisdiction
EP
Classification
—
Expires
2021-08-11
Drug substance claim
No
Drug product claim
No
Assignee
Hope Medical Enterprises Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.